Literature DB >> 15964805

Membrane insertion by anthrax protective antigen in cultured cells.

Maen Qa'dan1, Kenneth A Christensen, Lei Zhang, Thomas M Roberts, R John Collier.   

Abstract

The enzymatic moieties of anthrax toxin enter the cytosol of mammalian cells via a pore in the endosomal membrane formed by the protective antigen (PA) moiety. Pore formation involves an acidic pH-induced conformational rearrangement of a heptameric precursor (the prepore), in which the seven 2beta2-2beta3 loops interact to generate a 14-strand transmembrane beta-barrel. To investigate this model in vivo, we labeled PA with the fluorophore 7-nitrobenz-2-oxa-1,3-diazole (NBD) at cysteine residues introduced into the 2beta2-2beta3 loop. Each labeled PA was bound to CHO cells, and NBD fluorescence was monitored over time in stirred cell suspensions or by confocal microscopy. A strong increase was observed with NBD at positions 305, 307, 309, and 311, sites where side chains are predicted to face the bilayer, and little change was seen at residues 304, 306, 308, 310, and 312, sites where side chains are predicted to face the pore lumen. The increase at position 305 was inhibited by membrane-restricted quenchers, low temperature, or various reagents known to affect toxin action. Of the 24 NBD attachment sites examined, all but three gave results qualitatively consistent with the beta-barrel model. Besides supporting the beta-barrel model of membrane insertion, our results describe the time course of insertion and identify PA residues where NBD gives a strong signal upon membrane insertion in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964805      PMCID: PMC1156972          DOI: 10.1128/MCB.25.13.5492-5498.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Point mutations in anthrax protective antigen that block translocation.

Authors:  B R Sellman; S Nassi; R J Collier
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

2.  Stoichiometry of anthrax toxin complexes.

Authors:  Jeremy Mogridge; Kristina Cunningham; R John Collier
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

3.  The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.

Authors:  Jeremy Mogridge; Kristina Cunningham; D Borden Lacy; Michael Mourez; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

4.  Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin.

Authors:  Rajesh Ramachandran; Alejandro P Heuck; Rodney K Tweten; Arthur E Johnson
Journal:  Nat Struct Biol       Date:  2002-11

5.  Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel.

Authors:  Sen Zhang; Alan Finkelstein; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

6.  Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization.

Authors:  K E Beauregard; R J Collier; J A Swanson
Journal:  Cell Microbiol       Date:  2000-06       Impact factor: 3.715

7.  Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.

Authors:  Heather M Scobie; G Jonah A Rainey; Kenneth A Bradley; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

8.  Identification of the cellular receptor for anthrax toxin.

Authors:  K A Bradley; J Mogridge; M Mourez; R J Collier; J A Young
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

9.  Calcium dependence of the interaction between calmodulin and anthrax edema factor.

Authors:  Tobias S Ulmer; Sandriyana Soelaiman; Shipeng Li; Claude B Klee; Wei-Jen Tang; Ad Bax
Journal:  J Biol Chem       Date:  2003-04-29       Impact factor: 5.157

10.  Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process.

Authors:  Laurence Abrami; Shihui Liu; Pierre Cosson; Stephen H Leppla; F Gisou van der Goot
Journal:  J Cell Biol       Date:  2003-01-27       Impact factor: 10.539

View more
  7 in total

Review 1.  Ratcheting up protein translocation with anthrax toxin.

Authors:  Geoffrey K Feld; Michael J Brown; Bryan A Krantz
Journal:  Protein Sci       Date:  2012-03-30       Impact factor: 6.725

2.  Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin.

Authors:  Stephen J Juris; Roman A Melnyk; Robert E Bolcome; Joanne Chan; R John Collier
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

3.  Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.

Authors:  Jianjun Sun; Alexander E Lang; Klaus Aktories; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

Review 4.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

5.  Probing the pH-dependent prepore to pore transition of Bacillus anthracis protective antigen with differential oxidative protein footprinting.

Authors:  James G Smedley; Joshua S Sharp; Jeffrey F Kuhn; Kenneth B Tomer
Journal:  Biochemistry       Date:  2008-09-12       Impact factor: 3.162

6.  Defective mutations within the translocation domain of Clostridium difficile toxin B impair disease pathogenesis.

Authors:  Therwa Hamza; Zhifen Zhang; Roman A Melnyk; Hanping Feng
Journal:  Pathog Dis       Date:  2015-10-26       Impact factor: 3.166

7.  Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.

Authors:  Michael J Gubbins; Jody D Berry; Cindi R Corbett; Jeremy Mogridge; Xin Y Yuan; Lisa Schmidt; Brigitte Nicolas; Amin Kabani; Raymond S Tsang
Journal:  FEMS Immunol Med Microbiol       Date:  2006-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.